Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
Diabetes. 1997;46:1786-1791.
Bahijiri SM, Mira SA, Mufti AM, et al. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes.
Saudi Med J.
2000;21:831-837.
Eibl NL, Kopp HP, Nowak HR, et al. Hypomagnesemia in type II diabetes: Effect of a 3-month replacement therapy.
Diabetes Care.
1995;18:188-192.
Rabinowitz MB, Gonick HC, Levin SR, et al. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men.
Diabetes Care.
1983;6:319-327.
Trow LG, Lewis J, Greenwood RH, et al. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes.
Int J Vitam Nutr Res.
2000;70:14-18.
Jovanovic L, Gutierrez M, Peterson CM. Chromium supplementation for women with gestational diabetes mellitus.
J Trace Elem Med Biol.
1999;12:91-97.
Ravina A, Slezak L, Mirsky N, et al. Control of steroid-induced diabetes with supplemental chromium.
J Trace Elem Exp Med.
1999;12:375-378.
Ravina A, Slezak L, Mirsky N, et al. Reversal of corticosteroid-induced diabetes mellitis with supplemental chromium.
Diabet Med.
1999;16:164-167.
Gupta A, Gupta R, Lal B. Effect of
Trigonella foenum-graecum
(fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double-blind, placebo-controlled study.
J Assoc Physicians India.
2001;49:1057-1061.
Sharma RD, Sarkar A, Hazra DK, et al. Use of fenugreek seed powder in the management of non-insulin dependent diabetes mellitus.
Nutr Res.
1996;16:1331-1339.
Madar Z, Abel R, Samish S, et al. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics.
Eur J Clin Nutr.
1988;42:51-54.
Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes.
Eur J Clin Nutr.
1990;44:301-306.
Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients.
J Ethnopharmacol.
1990;30:295-305.
Shanmugasundaram ER, Rajeswari G, Baskaran K, et al. Use of
Gymnema sylvestre
leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus.
J Ethnopharmacol.
1990;30:281-294.
Indian Council of Medical Research (ICMR). Flexible dose open trial of Vijayasar in cases of newly-diagnosed non-insulin-dependent diabetes mellitus.
Indian J Med Res.
1998;108:24-29.
Joffe DJ, Freed SH. Effect of extended release
Gymnema sylvestre
leaf extract alone or in combination with oral hypoglycemics or insulin regimens for Type 1 and Type 2 diabetes.
Diabetes Control Newsl.
2001;76:1-4.
Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients.
Diabetes Care.
1995;18:1373-1375.
Vuksan V, Sievenpiper JL, Koo VY, et al. American ginseng
(Panax quinquefolius L)
reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus.
Arch Intern Med.
2000;160:1009-1013.
Vuksan V, Xu Z, Jenkins AL, et al. American ginseng
(Panax quinquefolium L.)
improves long term glycemic control in type 2 diabetes. Poster presented at: 60th scientific sessions of the American Diabetes Association; June 9-13, 2000; San Antonio, TX.
Sievenpiper JL, Stavro MP, Leiter LA, et al. Variable effects of ginseng: American ginseng
(Panax quinquefolius L.)
with a low ginsenoside content does not affect postprandial glycemia in normal subjects [abstract]. Diabetes. 2001;50(suppl 2):Abst #1771-PO.
Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, et al. Antidiabetic activity of
Aloe vera L.
juice. I. Clinical trial in new cases of diabetes mellitus.
Phytomedicine.
1996;3:241-243.
Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, et al. Antidiabetic activity of
Aloe vera L.
juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide.
Phytomedicine.
1996;3:245-248.
Okyar A, Can A, Akev N, et al. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models.
Phytother Res.
2001;15:157-161.
Ajabnoor MA. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice.
J Ethnopharmacol.
1990;28:215-220.
Matsumoto J. Vanadate, molybdate and tungstate for orthomolecular medicine.
Med Hypotheses.
1994;43:177-182.
Shamberger RJ. The insulin-like effects of vanadium.
J Adv Med.
1996;9:121-131.
Ramanadham S, Mongold JJ, Brownsey RW, et al. Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Am J Physiol.
1989;257:H904-H911.
Brichard SM, Okitolonda W, Henquin JC. Long-term improvement of glucose homeostasis by vanadate treatment in diabetic rats.
Endocrinology.
1988;123:2048-2053.
Kanthasamy A, Sekar N, Govindasamy S. Vanadate substitutes insulin role in chronic experimental diabetes.
Indian J Exp Biol.
1988;26:778-780.
Shechter Y. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes.
Diabetes.
1990;39:1-5.
Challiss RA, Leighton B, Lozeman FJ, et al. Effects of chronic administration of vanadate to the rat on the sensitivity of glycolysis and glycogen synthesis in skeletal muscle to insulin.
Biochem Pharmacol.
1987;36:357-361.
Sakurai H, Tsuchiya K, Nakatsuka M, et al. Insulin-like effect of vanadyl ion on streptozocin-induced diabetic rats.
J Endocrinol.
1990;126:451-459.
Pederson RA, Ramanadham S, Buchan AM, et al. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Diabetes.
1989;38:1390-1395.
Myerovitch J, Farfel A, Sack J, et al. Oral administration of vanadate normalizes blood glucose levels in streptozocin-treated rats. Characterization and mode of action.
J Biol Chem.
1987;262:6658-6662.
Heylinger CE, Tahiliani AG, McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats.
Science.
1985;227:1474-1477.
Boden G, Chen X, Ruiz J, et al. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
Metabolism.
1996;45:1130-1135.
Cohen N, Halberstam M, Shlimovich P, et al. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.
J Clin Invest.
1995;95:2501-2509.
Goldfine AB, Folli F, Patti ME, et al. Effects of sodium vanadate and in vitro insulin action in diabetes [abstract].
Clin Res.
1994;42:116A.
Halberstam M, Cohen N, Shlimovich P, et al. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Diabetes.
1996;45:659-666.
Goldfine AB, Patti ME, Zuberi L, et al. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
Metabolism.
2000;49:400-410.
Srivastava AK. Anti-diabetic and toxic effects of vanadium compounds.
Mol Cell Biochem.
2000;206:177-182.
Yaniv Z, Dafni A, Friedman J, et al. Plants used for the treatment of diabetes in Israel.
J Ethnopharmacol.
1987;19:145-151.
Teixeira CC, Pinto LP, Kessler FHP, et al. The effect of
Syzygium cumini (L.)
skeels on post-prandial blood glucose levels in non-diabetic rats and rats with streptozotocin-induced diabetes mellitus.
J Ethnopharmacol.
1997;56:209-213.
Bever BO, Zahnd GR. Plants with oral hypoglycaemic action.
Q J Crude Drug Res.
1979;17:139-196.
Mathew PT, Augusti KT. Hypoglycaemic effects of onion,
Allium cepa Linn.
on diabetes mellitus—a preliminary report.
Indian J Physiol Pharmacol.
1975;19:213-217.
Manickam M, Ramanathan M, Jahromi MAF, et al. Antihyperglycemic activity of phenolics from
Pterocarpus marsupium.J Nat Prod.
1997;60:609-610.
Ahmad F, Khalid P, Khan MM, et al. Insulin-like activity in (-) epicatechin.
Acta Diabetol.
1989;26:291-300.
Stern E. Successful use of Atriplex halimus in the treatment of type II diabetic patients. A preliminary study. Tel Aviv, Israel: Zamenhoff Medical Center; 1989. (Unpublished.)
Earon G, Stern E, Lavosky H. Successful use of Atriplex hamilus in the treatment of type 2 diabetic patients. Controlled clinical research report on the subject of Atriplex. Jerusalem: Hebrew University; 1989. (Unpublished.)
Azad Khan AK, Akhtar S, Mahtab H. Treatment of diabetes mellitus with
Coccinia indicaBr Med J.
1980;280:1044.
Welihinda J, Karunanayake EH, Sheriff MHR, et al. Effect of
Momordica charantia
on the glucose tolerance in maturity onset diabetes.
J Ethnopharmacol.
1986;17:277-282.
Akhtar MS. Trial of
Momordica charantia Linn (Karela)
powder in patients with maturity-onset diabetes.
J Pak Med Assoc.
1982;32:106-107.
Leatherdale BA, Panesar RK, Singh G, et al. Improvement in glucose tolerance due to
Momordica charantia (karela).Br Med J.
(Clin Res Ed.) 1981;282:1823-1824.
Cignarella A, Nastasi M, Cavalli E, et al. Novel lipid-lowering properties of
Vaccinium myrtillus L.
leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate.
Thromb Res.
1996;84:311-322.
Adler JH, Lazarovici G, Marton M, et al. The diabetic response of weanling sand rats
(Psammomys obesus)
to diets containing different concentrations of salt bush
(Atriplex halimus).Diabetes Res.
1986;3:169-171.
Aharonson Z, Shani J, Sulman FG. Hypoglycaemic effect of the salt bush
(Atriplex halimus)—a feeding source of the sand rat
(Psammomys obesus)Diabetologia
1969;5:379-383.
Shani J, Ahronson Z, Sulman FG, et al. Insulin-potentiating effect of salt bush
(Atriplex halimus)
ashes.
Isr J Med Sci.
1972;8:757-758.
Chattopadhyay RR. Hypoglycemic effect of
Ocimum sanctum
leaf extract in normal and streptozotocin diabetic rats.
Indian J Exp Biol.
1993;31:891-893.
Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus.
Int J Clin Pharmacol Ther.
1996;34:406-409.
Frati AC, Gordillo BE, Altamirano P, et al. Influence of nopal intake upon fasting glycemia in type II diabetics and healthy subjects.
Arch Invest Med (Mex). 1991;22:51-56.
Frati-Munari AC, Del Valle-Martinez LM, Ariza-Andraca CR, et al. Hypoglycemic action of different doses of nopal
(Opuntia streptacantha Lemaire)
in patients with type II diabetes mellitus [in Spanish; English abstract].
Arch Invest Med (Mex). 1989;20:197-201.
Frati-Munari AC, Gordillo BE, Altamirano P, et al. Hypoglycemic effect of
Opuntia streptacantha Lemaire
in NIDDM.
Diabetes Care.
1988;11:63-66.
Frati-Munari AC, Fernandez-Harp JA, de la Riva H, et al. Effects of nopal (
Opuntia
sp.) on serum lipids, glycemia and body weight.
Arch Invest Med (Mex). 1983;14:117-125.
Frati-Munari AC, de Leon C, Ariza-Andraca R, et al. Effect of a dehydrated extract of nopal
(Opuntia ficus indica Mill.)
on blood glucose [in Spanish; English abstract].
Arch Invest Med
(Mex). 1989;20:211-216.
Frati Munari AC, Quiroz Lazaro JL, Altamirano Bustamante P, et al. The effect of various doses of nopal
(Opuntia streptacantha Lemaire)
on the glucose tolerance test in healthy individuals [in Spanish; English abstract].
Arch Invest Med (Mex).
1988;19:143-148.
Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
Diabetes Care.
1999;22:913-919.
Doi K. Effect of konjac fibre (glucomannan) on glucose and lipids.
Eur J Clin Nutr.
1995;(suppl 3):190-197.
Ahmad N, Hassan MR, Halder H, et al. Effect of
Momordica charantia (Karolla)
extracts on fasting and postprandial serum glucose levels in NIDDM patients.
Bangladesh Med Res Counc Bull.
1999;25:11-13.
Jayasooriya AP, Sakono M, Yukizaki C, et al. Effects of momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.
J Ethnopharmacol.
2000;72:331-336.
Subramaniam A, Stocker C, Sennitt MV, et al. Guggul lipid reduces insulin resistance and body weight gain in C57B1/6 lep/lep mice [abstract].
Int J Obes Relat Metab Disord.
2001;25(suppl 2):S24.
Piatti PM, Monti LD, Valsecchi G, et al. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients.
Diabetes Care.
2001;24:875-880.
Konno S, Maitake SX-fraction: Possible hypoglycemic effect on diabetes mellitus.
Altern Comp Ther.
2001;7:366-370.
Belury MA, Mahon A, Shi L. Role of conjugated linoleic acid (CLA) in the management of type 2 diabetes: evidence from Zucker diabetic (fa/fa) rats and human subjects. Paper presented at: 220th ACS National Meeting; August 20-24,2000; Washington, DC. Abstract AGFD 26.
Riserus U, Arner P, Brismar K, et al. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome.
Diabetes Care.
2002;25:1516-1521.
Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, et al. Study of the anti-hyperglycemic effect of plants used as antidiabetics.
J Ethnopharmacol.
1998;61:101-110.
Chattopadhyay RR. A comparative evaluation of some blood sugar lowering agents of plant origin.
J Ethnopharmacol.
1999;67:367-372.
Pari L, Maheswari JU. Hypoglycaemic effect of
Musa sapientum L.
in alloxan-induced diabetic rats.
J Ethnopharmacol.
1999;68:321-325.
Roman Ramos R, Lara Lemus A, Alarcon Aguilar F, et al. Hypoglycemic activity of some antidiabetic plants.
Arch Med Res.
1992;23:105-109.
Khosla P, Bhanwra S, Singh J, et al. A study of hypoglycaemic effects of
Azadirachta indica
(Neem) in normal and alloxan diabetic rabbits.
Indian J Physiol Pharmacol.
2000;44:69-74.
Roman-Ramos R, Flores-Saenz JL, Alarcon-Aguilar FJ. Anti-hyperglycemic effect of some edible plants.
J Ethnopharmacol.
1995;48:25-32.
Malinow MR, McLaughlin P, Stafford C. Alfalfa seeds: effects on cholesterol metabolism.
Experientia.
1980;36:562-564.
Swanston-Flatt SK, Day C, Bailey CJ, et al. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice.
Diabetologia.
1990;33:462-464.
Ichiki H, Miura T, Kubo M, et al. New antidiabetic compounds, mangiferin and its glucoside.
Biol Pharm Bull.
1998;21:1389-1390.
Shekhar KC, Achike FI, Kaur G, et al. A preliminary evaluation of the efficacy and safety of Cogent db (an ayurvedic drug) in the glycemic control of patients with type 2-diabetes.
J Altern Complement Med.
2002;8:445-457.
Agrawal RP, Sharma A, Dua AS, et al. A randomized placebo controlled trial of Inolter (herbal product) in the treatment of type 2 diabetes.
J Assoc Physicians India.
2002;50:391-393.
Mohan V. Evaluation of Diabecon (D-400) as an antidiabetic agent—A double blind placebo controlled trial in NIDDM patients with secondary failure to oral drugs.
Indian Journal of Clinical Practice.
1998;8:9,18.
Paolisso G, D'Amore A, Galzerano D, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients.
Diabetes Care.
1993;16:1433-1437.
Paolisso G, D'Amore A, Giugliano D, et al. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients.
Am J Clin Nutr.
1993;57:650-656.
Mingrone G, Greco AV, Capristo E, et al. L-carnitine improves glucose disposal in type 2 diabetic patients.
J Am Coll Nutr.
1999;18:77-82.
Singh RB, Niaz MA Rastogi SS, et al. Effect of hydrosoluble coenzyme Q10
on blood pressures and insulin resistance in hypertensive patients with coronary artery disease.
J Human Hypertens.
1999;13:203-208.
Hodgson JM, Watts GF, Playford DA, et al. Coenzyme Q(10) improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.
Eur J Clin Nutr.
2002;56:1137-1142.
Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.
Free Radic Biol Med.
1999;27:309-314.
Pozzilli P, Visalli N, Signore A, et al. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
Diabetologia.
1995;38:848-852.
Ludvigsson J, Samuelsson U, Johansson C, et al. Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double-blind placebo-controlled study.
Diabetes Metab Res Rev.
2001;17:131-136.
Elamin A, Tuvemo T. Magnesium and insulin-dependent diabetes mellitus.
Diabetes Res Clin Pract.
1990;10:203-209.
Tosiello L. Hypomagnesemia and diabetes mellitus: a review of clinical implications.
Arch Intern Med.
1996;156:1143-1148.
Schmidt LE, Arfken CL, Heins JM. Evaluation of nutrient intake in subjects with non-insulin-dependent diabetes mellitus.
J Am Diet Assoc.
1994;94:773-774.
Blostein-Fujii A, DeSilvestro RA, Frid D, et al. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5'- nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro.
Am J Clin Nutr.
1997;66:639-642.
Sjogren A, Floren CH, Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus.
Acta Med Scand.
1988;224:461-465.
Cunningham JJ, Ellis SL, McVeigh KL, et al. Reduced mononuclear leukocyte ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin C.
Metabolism.
1991;40:146-149.
Sinclair AJ, Taylor PB, Lunec J, et al. Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C.
Diabet Med.
1994;11:893-898.
Will JC, Byers T. Does diabetes mellitus increase the requirement for vitamin C?
Nutr Rev.
1996;54:193-202.
Franconi F, Bennardini F, Mattana A, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation.
Am J Clin Nutr.
1995;61:1115-1119.
Kosenko LG. The content of some trace elements in the blood of patients suffering from diabetes mellitus [in Russian; English abstract].
Klin Med (Mosk).
1964;42:113-116.
Adams JF, Clark JS, Ireland JT, et al. Malabsorption of vitamin B12
and intrinsic factor secretion during biguanide therapy.
Diabetologia.
1983;24:16-18.
Bauman WA, Shaw S, Jayatilleke E, et al. Increased intake of calcium reverses vitamin B12
malabsorption induced by metformin.
Diabetes Care.
2000;23:1227-1231.
Elliott RB, Pilcher CC, Fergusson DM, et al. A population based strategy to prevent insulin-dependent diabetes using nicotinamide.
J Pediatr Endocrinol Metab.
1996;9:501-509.
Lampeter EF, Klinghammer A, Scherbaum WA, et al. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.
Diabetes.
1998;47:980-984.
Ludvigsson J, Samuelsson U, Johansson C, et al. Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double-blind placebo-controlled study.
Diabetes Metab Res Rev.
2001;17:131-136.
Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type I diabetes: a birth-cohort study.
Lancet.
2001;358:1500-1503.
The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus.
Diabetologia.
1999;42:51-54.
Stene LC, Ulriksen J, Magnus P, et al. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring.
Diabetologia.
2000;43:1093-1098.
Feskens EJ, Bowles CH, Kromhout D. Carbohydrate intake and body mass index in relation to the risk of glucose intolerance in an elderly population.
Am J Clin Nutr.
1991;54:136-140.
Feskens, EMJ, Kromhout D. Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen Study.
Am J Epidemiol.
1989;130:1001-1008.
Feskens EJM, Kromhout D. Habitual dietary intake and glucose tolerance in middle-aged euglycaemic men.
Int J Epidemiol.
1990;19:953-959.
Keen H, Thomas BJ, Jarrett RJ, Fuller JH. Nutrient intake, adiposity, and diabetes.
Br Med J.
1979;1:655-658.
Bennett PH, Knowler WC, Baird HR, Butler WJ, Pettitt DJ, Reid JM. Diet and the development of noninsulin-dependent diabetes mellitus: an epidemiological perspective. In: Pozza G, et al, eds.
In: Diet, Diabetes, and Atherosclerosis.
New York: Raven Press, 1984:109-199.
Harlan LC, Harlan, WR, Landis JR, Goldstein NG. Factors associated with glucose tolerance in US adults.
Am J Epidemiol
1987;126:674-684.
Trevisan M, Krogh V, Freudenheim J, et al. Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors.
JAMA.
1990;263:688-695.
Baird JD. Diet and the development of clinical diabetes.
Acta Diabetol Lat.
1972;9(suppl 1):621-639.
Lundgren H, Bengtsson C, Blohmé G, et al. Dietary habits and incidence of noninsulin-dependent diabetes mellitus in a population of women in Gothenburg, Sweden.
Am J Clin Nutr.
1989;49:708-712.
Feskens EJ, Kromhout D. Habitual dietary intake and glucose tolerance in euglycaemic men: the Zutphen Study.
Int J Epidemiol.
1990;19:953-959.
Feskens EJ, Kromhout D. Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen Study.
Am J Epidemiol.
1989;130:1101-1108.
Meyer KA, Kushi LH, Jacobs DR Jr, et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women.
Am J Clin Nutr.
2000;71:921-930.
Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, et al. Related Articles: Dietary fiber, glycemic load, and risk of NIDDM in men.
Diabetes Care.
1997;20:545-550.
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women.
JAMA.
1997;277:472-477.
van Dam RM, Visscher AW, Feskens EJ, et al. Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study.
Eur J Clin Nutr.
2000;54:726-731.
Sato Y. Diabetes and life-styles: role of physical exercise for primary prevention.
Br J Nutr.
2000;84:S187-S190.
Ajiboye R, Harding JJ. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione.
Exp Eye Res.
1989;49:31-41.
Shankar RR, Zhu JS, Baron AD. Glucosamine infusion in rats mimics the beta-cell dysfunction of non- insulin-dependant diabetes mellitus.
Metabolism.
1998;47:573-577.
Patti ME, Virkamaki A, Landaker EJ, et al. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skelatal muscle.
Diabetes.
1999;48:1562-1571.
Virkamaki A, Yki-Jarvinen H. Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart.
Diabetes.
1999;48:1101-1107.
Almada AL, Harvey PW, Platt KJ. Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in nondiabetic individuals [abstract].
FASEB J.
2000;14:A750.
Monauni T, Zenti MG, Cretti A, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans.
Diabetes.
2000;49:926-935.
Kudolo GB. The effect of three- month ingestion of
Ginko Biloba
extract (EGb 761) on pancreatic b-cell function in response to glucose loading in individuals with non-insulin dependent diabetes mellitus.
J Clin Pharmacol.
2001;41:600-611.
Grundy SM, Vega GL, McGovern ME, et al. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Arch Intern Med.
2002;162:1568-1576.
Elam MB, Hunninghake DB, Davis KB, et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients With diabetes and peripheral arterial disease. The ADMIT Study: a randomized trial.
JAMA.
2000;284:1263-1270.
Montori VM, Farmer A, Wollan PC, et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Diabetes Care.
2000;23:1407-1415.
Ghosh D, Bhattacharya B, Mukherjee B, et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus.
J Nutr Biochem.
2002;13:690-697.
Yeh GY, Eisenberg DM, Kaptchuk TJ, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes.
Diabetes Care.
2003;26:1277-1294.
Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety.
Am J Health Syst Pharm.
2003;60:356-359.
Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
Diabetes Care.
2003;26:1147-1152.
Chen HL, Sheu WH, Tai TS, et al. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects-a randomized double-blind trial.
J Am Coll Nutr.
2003;22:36-42.
Ludvik BH, Mahdjoobian K, Waldhaeusl W, et al. The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study.
Diabetes Care.
2002;25:239-240.
Vray M, Attali JR. Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.
Diabete Metab.
1995;21:433-439.
Field T, Hernandez-Reif M, LaGreca A, et al. Massage therapy lowers blood glucose levels in children with diabetes mellitus.
Diabetes Spectrum.
1997;10:237-239.
Barringer TA, Kirk JK, Santaniello AC, et al. Effect of a multivitamin and mineral supplement on infection and quality of life. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
2003;138:365-371.
Houweling ST, Kleefstra N, Jansman GA, et al. Effects of chromium treatment in patients with poorly controlled, insulin-treated Type 2 diabetes mellitus [abstract 756]. 18th International Diabetes Federation Congress, Paris, August 24-29, 2003.
Sievenpiper JL, Arnason JT, Leiter LA, et al. Null and opposing effects of Asian ginseng (Panax ginseng
CA Meyer) on acute glycemia: results of two acute dose escalation studies.
J Am Coll Nutr.
2003;22:524-532.
Vuksan V, Sievenpiper JL, Sung MK, et al. Safety and efficacy of Korean Red Ginseng Intervention (SAEKI): results of a randomized, double-blind, placebo-controlled crossover trial in type 2 diabetes [abstract 587P]. American Diabetes Association 63rd Annual Scientific Sessions. New Orleans, LA, June 13-17, 2003.
Imparl-Radosevich J, Deas S, Polansky MM, et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signaling.
Horm Res.
1998;50:177-182.
Onderoglu S, Sozer S, Erbil KM, et al. The evaluation of long-term effects of cinnamon bark and olive leaf on toxicity induced by streptozotocin administration to rats.
J Pharm Pharmacol.
1999;51:1305-1312.
Khan A, Safdar M, Ali Khan MM, et al. Cinnamon improves glucose and lipids of people with Type 2 diabetes.
Diabetes Care.
2003;26:3215-3218.
Manning PJ, Sutherland WH, Walker RJ, et al. Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects.
Diabetes Care.
2004;27:2166-2171.
Hosoda K, Wang MF, Liao ML, et al. Antihyperglycemic effect of oolong tea in type 2 diabetes.
Diabetes Care.
2003;26:1714-1718.
Ludvik B, Neuffer B, Pacini G. Efficacy of
Ipomoea batatas
(Caiapo) on diabetes control in Type 2 diabetic subjects treated with diet.
Diabetes Care.
2004;27:436-440.
Liu X, Wei J, Tan F, et al. Antidiabetic effect of Pycnogenol® French maritime pine bark extract in patients with diabetes type II.
Life Sci.
2004;75:2505-2513.
Kawano H, Yasue H, Kitagawa A, et al. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men.
J Clin Endocrinol Metab.
2003;88:3190-3195.
Singh SK, Unnikrishnan AG. A new herbal combination (Hyponidd) in the management of Type 2 diabetes [abstract 848]. 18th International Diabetes Federation Congress, Paris, August 24-29, 2003.
Sangsuwan C, Udompanthurak S, Vannasaeng S, et al. Randomized controlled trial of
Tinospora crispa
for additional therapy in patients with type 2 diabetes mellitus.
J Med Assoc Thai.
2004;87:543-546.
Lindstrom J, Eriksson JG, Valle TT, et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial.
J Am Soc Nephrol.
2003;14:S108-113.
Moloney F, Yeow TP, Mullen A, et al. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus.
Am J Clin Nutr.
2004;80:887-895.
Riserus U, Arner P, Brismar K, et al. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome.
Diabetes Care.
2002;25:1516-1521.
Riserus U, Vessby B, Arner P, et al. Supplementation with trans10 cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity.
Diabetologia.
2004 May 28. [Epub ahead of print]
Sugiyama T, Kubota Y, Shinozuka K, et al.
Ginkgo biloba
extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats.
Life Sci.
2004;75:1113-1122.
Scroggie DA, Albright A, Harris MD. The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.
Arch Intern Med.
2003;163:1587-1590.
Yu JG, Boies SM, Olefsky JM. The effect of oral glucosamine sulfate on insulin sensitivity in human subjects.
Diabetes Care.
2003;26:1941-1942.
Tannis AJ, Barban J, Conquer JA. Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals.
Osteoarthritis Cartilage.
2004;12:506-511.
Kleefstra N, Houweling ST, Jansman FG, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese western population: a randomized, double-blind, placebo-controlled trial.
Diabetes Care.
2006;29:521-525.
Sievenpiper JL, Sung MK, Di Buono M, et al. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies.
J Am Coll Nutr.
2006;25:100-107
I Sievenpiper JL, Arnason JT, Leiter LA, et al. Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides.
J Am Coll Nutr.
2004;23:248-58.
Vuksan V, Sievenpiper JL. Herbal remedies in the management of diabetes: lessons learned from the study of ginseng.
Nutr Metab Cardiovasc Dis.
2005;15:149-160.
Vanschoonbeek K, Thomassen BJ, Senden JM, et al. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients.
J Nutr.
2006;136:977-980.
Mang B, Wolters M, Schmitt B, et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2.
Eur J Clin Invest.
2006;36:340-344.
Boshtam M, Rafiei M, Golshadi ID, et al. Long term effects of oral vitamin E supplement in type II diabetic patients.
Int J Vitam Nutr Res.
2006;75:341-346.
Luo J, Van Yperselle M, Rizkalla SW, et al. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics.
J Nutr.
2000;130:1572-1577.
Alles MS, de Roos NM, Bakx JC, van de Lisdonk E, Zock PL, Hautvast GA. Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes.
Am J Clin Nutr.
1999;69:64-69.
Wang L, Liu S, Manson JE, et al. The consumption of lycopene and tomato-based food products is not associated with the risk of type 2 diabetes in women.
J Nutr.
2006;136:620-625.
al-Hader AA, Hasan ZA, Aqel MB. Hyperglycemic and insulin release inhibitory effects of Rosmarinus officinalis.
J Ethnopharmacol.
1994 Jul 22;43:217-221.
Pei D, Hsieh CH, Hung YJ, et al. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Metabolism.
2006;55:923-927.
Ahuja KD, Robertson IK, Geraghty DP, et al. Effects of chili consumption on postprandial glucose, insulin, and energy metabolism.
Am J Clin Nutr.
2006;84:63-69.
Martin J, Wang ZQ, Zhang XH, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.
Diabetes Care.
2006;29:1826-1832.
Vuksan V, Sung MK, Sievenpiper JL, et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, double-blind, placebo-controlled study of efficacy and safety.
Nutr Metab Cardiovasc Dis.
2006 Jul 21. [Epub ahead of print]
Kudolo GB, Wang W, Elrod R, et al. Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects-A randomized double-blind placebo-controlled crossover study.
Clin Nutr.
2005 Nov 14. [Epub ahead of print]
Lucotti PC, Setola E, Monti LD, et al. Beneficial effects of oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin resistant type 2 diabetic patients
Am J Physiol Endocrinol Metab.
2006 Jun 13. [Epub ahead of print]
Cabrera-Rode E, Molina G, Arranz C, et al. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
Autoimmunity.
2006;39:333-340.
Gale EA, Bingley PJ, Emmett CL, et al. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Lancet.
2004;363:925-931.
Collene AL, Hertzler SR, Williams JA, et al. Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults.
Nutrition.
2005;21:848-854.
Heacock PM, Hertzler SR, Williams JA, et al. Effects of a medical food containing an herbal alpha-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults.
J Am Diet Assoc.
2005;105:65-71.
Song Y, He K, Levitan EB, et al. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
Diabet Med.
2006;23:1050-1056.
Liu S, Lee IM, Song Y, et al. Vitamin E and risk of type 2 diabetes in the Women's Health Study Randomized Controlled Trial.
Diabetes.
2006;55:2856-2862.
Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British Birth Cohort: the role of obesity.
Diabetes Care.
2006;29:2244-2246.
Elder C, Aickin M, Bauer V, et al. Randomized trial of a whole-system ayurvedic protocol for type 2 diabetes.
Altern Ther Health Med.
2006;12:24-30.
Hussain SA, Khadim HM, Khalaf BH, et al. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin.
Saudi Med J.
2006;27:1483-1488.
Reay JL, Kennedy DO, Scholey AB. The glycaemic effects of single doses of Panax ginseng in young healthy volunteers.
Br J Nutr.
2006;96:639-642.
Syvertsen C, Halse J, Hoivik HO, et al. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
Int J Obes (Lond).
2006 Oct 10. [Epub ahead of print]
Huseini HF, Larijani B, Heshmat R, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
Phytother Res.
2006 Oct 30. [Epub ahead of print]
Muniyappa R, Karne RJ, Hall G, et al. Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects.
Diabetes.
2006;55:3142-3150.
Ward NC, Wu JH, Clarke MW, et al. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
J Hypertens.
2007;25:227-234.
Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial.
Diabetes Technol Ther.
2006;8:636-643.
Kleefstra N, Houweling ST, Bakker SJ, et al. Chromium treatment has no effect in patients with type 2 diabetes mellitus in a western population: a randomized, double-blind, placebo-controlled trial.
Diabetes Care.
2007 Feb 15. [Epub ahead of print]
Hsu CH, Liao YL, Lin SC, et al. The mushroom agaricus blazei murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.
J Altern Complement Med.
2007;13:97-102.
Basu R, Man CD, Campioni M, et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women.
Diabetes.
2007;56:753-766.
Altschuler JA, Casella SJ, Mackenzie TA, et al. The effect of cinnamon on A1C among adolescents with type 1 diabetes.
Diabetes Care.
2007;30:813-816.
Wang JG, Anderson RA, Chu MC, et al. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study.
Fertil Steril.
2007 Feb 9. [Epub ahead of print]
Gualano B, Novaes RB, Artioli GG, et al. Effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic training.
Amino Acids.
2007 Mar 30. [Epub ahead of print]
Pi-Sunyer FX. How effective are lifestyle changes in the prevention of type 2 diabetes mellitus? Nutr Rev. 2007;65:101-110.
Dans AM, Villarruz MV, Jimeno CA, et al. The effect of Momordica charantia capsule preparation on glycemic control in type 2 Diabetes Mellitus needs further studies. J Clin Epidemiol. 2007;60:554-559.
Albarracin CA, Fuqua BC, Evans JL, et al. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev. 2007 May 16. [Epub ahead of print]
Atteritano M, Marini H, Minutoli L, et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a 2-years randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2007 May 22. [Epub ahead of print]
Fukino Y, Ikeda A, Maruyama K, et al. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr. 2007 Jun 6. [Epub ahead of print
Han JR, Deng B, Sun J, et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007;56:985-991.
Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term Selenium supplementation on the incidence of Type 2 diabetes. Ann Intern Med. 2007 July 9. [Epub ahead of print]
Williams JA, Choe YS, Noss MJ, et al. Extract of oblonga lowers acute glycemia in patients with type 2 diabetes. Am J Clin Nutr. 2007;86:124-130.
Ouellet V, Marois J, Weisnagel SJ, et al. Dietary cod protein improves insulin sensitivity in insulin-resistant men and women: a randomized controlled trial. Diabetes Care. 2007 Aug 6. [Epub ahead of print]
Albert SG, Fishman Oiknine R, Parseghian S, et al. The effect of glucosamine on serum high density lipoprotein cholesterol and apolipoprotein AI levels in people with diabetes mellitus. Diabetes Care. 2007 Aug 6. [Epub ahead of print]
Vuksan V, Whitham D, Sievenpiper JL, et al. Supplementation of conventional therapy with the novel grain salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care. 2007 Aug 8. [Epub ahead of print]
Suppapitiporn S, Kanpaksi N, Suppapitiporn S. The effect of cinnamon cassia powder in type 2 diabetes mellitus. J Med Assoc Thai. 2006;89(suppl 3):S200-S205.
Gale EA, Beattie S, Hu J, et al. Recruitment to a clinical trial improves glycemic control in patients with diabetes. Diabetes Care. 2007 Sep 5. [Epub ahead of print]
Sobenin IA, Nedosugova LV, Filatova LV, et al. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study. Acta Diabetol. 2007 Sep 6. [Epub ahead of print]
Mackenzie T, Leary L, Brooks WB. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism. 2007;56:1340-1344.
Baker WL, Gutierrez-Williams G, White CM, et al. The effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2007 Oct 1. [Epub ahead of print]
Bryans JA, Judd PA, Ellis PR. The effect of consuming instant black tea on postprandial plasma glucose and insulin concentrations in healthy humans. J Am Coll Nutr. 2007;26:471-477.
Kataja-Tuomola M, Sundell JR, Mannisto S, et al. Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. Diabetologia. 2007 Nov 10. [Epub ahead of print]
Kuriyan R, Rajendran R, Bantwal G, et al. Effect of supplementation of Coccinia cordifolia extract on newly detected diabetic patients. Diabetes Care. 2007 Nov 13. [Epub ahead of print]
Smith DM, Pickering RM, Lewith GT. A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus. QJM. 2008 Mar 4.
Li Y, Huang TH, Yamahara J. Salacia root, a unique Ayurvedic medicine, meets multiple targets in diabetes and obesity. Life Sci. 2008 Mar 28.
Ramel A, Martinez A, Kiely M, et al. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia. 2008 May 20.
Shidfar F, Keshavarz A, Hosseyni S, et al. Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients. East Mediterr Health J. 2008;14:305-313.
Last reviewed July 2008 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.